Suven Life Sciences is currently trading at Rs. 74.50, up by 0.15 points or 0.20% from its previous closing of Rs. 74.35 on the BSE.
The scrip opened at Rs. 74.95 and has touched a high and low of Rs. 75.05 and Rs. 74.20 respectively. So far 114141 shares were traded on the counter.
The BSE group 'B' stock of face value Rs. 1 has touched a 52 week high of Rs. 83.40 on 12-Nov-2013 and a 52 week low of Rs. 22.00 on 13-Jun-2013.
Last one week high and low of the scrip stood at Rs. 77.00 and Rs. 71.60 respectively. The current market cap of the company is Rs. 870.37 crore.
The promoters holding in the company stood at 64.76% while Institutions and Non-Institutions held 0.89% and 34.35% respectively.
Suven Life Sciences, a bio-pharmaceutical and contract research and manufacturing company, has granted an exclusive license and right to distribute and market its Malathion Lotion USP 0.5% w/v in USA, Canada and Mexico to Taro Pharmaceuticals North America, Inc., a subsidiary of Taro Pharmaceutical Industries.
Malathion lotion is indicated for patients infected with Pediculus humanus capitis (head lice and their ova) of the scalp hair. In consideration for the exclusive license and right to distribute and market Malathion Lotion 0.5%w/v USP in North America, Taro will pay Suven a royalty and the arrangement is effective until April 2028 unless otherwise terminated.
Suven Life Science is a biopharmaceutical company focused on discovering, developing and commercializing novel pharmaceutical products, which are first in class or best in class CNS therapies through the use of GPCR targets.
Company Name | CMP |
---|---|
Sun Pharma Inds. | 1814.50 |
Dr. Reddys Lab | 1340.80 |
Cipla | 1476.45 |
Lupin | 2160.20 |
Zydus Lifesciences | 972.95 |
View more.. |